Grundium Oy, a leader in advanced digital scanning backed by US-based healthcare private equity firm EW Healthcare Partners, has announced the acquisition of Visiopharm A/S, a leading AI-driven precision pathology software company. The acquisition is a significant step towards Grundium’s strategy to build a broader digital and computational pathology platform. The combined business brings together complementary capabilities from Grundium’s cutting-edge imaging platform and Visiopharm’s AI-driven precision pathology software, creating an accessible end-to-end solution for diagnostic laboratories, biopharmaceutical development, and research.
Read the full article: Grundium Acquires Visiopharm to Create Integrated Precision Pathology Platform //
Source: https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/grundium-acquires-visiopharm-to-create-integrated-precision-pathology-1168733